Talk BIO to Me Transistor (https://transistor.fm) https://feeds.transistor.fm/talk-bio-to-me What happens when you mix a disco-dancin' podcaster with some of the brightest minds in biotech? You get Talk BIO to Me. Recorded live at SynBioBeta, this interview series takes you inside the world of synthetic biology through conversations with pioneering scientists, founders, investors, and AI innovators building the future of life. Chorus Studios LLC 77e09f00-ebc3-52e2-85e5-c727eed95e96 yes Talk BIO to Me... en Mon, 29 Jun 2026 17:26:16 -0400 Mon, 29 Jun 2026 17:27:10 -0400 https://img.transistorcdn.com/8hiloilv7fih8Loap6tqCIPrQ1D14-Ju0wZDcPmt2Tc/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MDA2/ZGI1OTIwZTE0NTZl/MTVhMzkzYTUzZjc0/ZGE5NS5wbmc.jpg Talk BIO to Me episodic Chorus Studios What happens when you mix a disco-dancin' podcaster with some of the brightest minds in biotech? You get Talk BIO to Me. Recorded live at SynBioBeta, this interview series takes you inside the world of synthetic biology through conversations with pioneering scientists, founders, investors, and AI innovators building the future of life. What happens when you mix a disco-dancin' podcaster with some of the brightest minds in biotech. biotech, synthetic, AI, futurism, biology, pharmaceuticals, research Florence Lumsden flo@chorus-studios.com No No Can AI Debug Biology? Nicholas Larus-Stone, AI @ Benchling 4 4 Can AI Debug Biology? Nicholas Larus-Stone, AI @ Benchling full ea2422bf-503a-4a34-8a58-e7f2b091da7b https://talkBIOtome.transistor.fm/4 For years, AI has helped scientists organize data and streamline research, but it's now beginning to tackle biology's toughest scientific challenges. In this episode, Flo sits down with Nicholas, Head of AI at Benchling, to discuss why the physical world has been AI's biggest blind spot—and why that's finally changing. From generative protein design to the future of drug discovery and diagnostics, Nicholas explains how biology is increasingly being engineered in silico (by compute) before it reaches the lab. Plus, he shares what excites him most about the next wave of AI-powered biology - the future of the bioeconomy!

Connect:
Nicholas on Linkedin: https://www.linkedin.com/in/nlarusstone/
Benchling: https://www.benchling.com/

]]> For years, AI has helped scientists organize data and streamline research, but it's now beginning to tackle biology's toughest scientific challenges. In this episode, Flo sits down with Nicholas, Head of AI at Benchling, to discuss why the physical world has been AI's biggest blind spot—and why that's finally changing. From generative protein design to the future of drug discovery and diagnostics, Nicholas explains how biology is increasingly being engineered in silico (by compute) before it reaches the lab. Plus, he shares what excites him most about the next wave of AI-powered biology - the future of the bioeconomy!

Connect:
Nicholas on Linkedin: https://www.linkedin.com/in/nlarusstone/
Benchling: https://www.benchling.com/

]]> Mon, 29 Jun 2026 16:37:22 -0400 Chorus Studios Chorus Studios 579 For years, AI has helped scientists organize data and streamline research, but it's now beginning to tackle biology's toughest scientific challenges. In this episode, Flo sits down with Nicholas, Head of AI at Benchling, to discuss why the physical world has been AI's biggest blind spot—and why that's finally changing. From generative protein design to the future of drug discovery and diagnostics, Nicholas explains how biology is increasingly being engineered in silico (by compute) before it reaches the lab. Plus, he shares what excites him most about the next wave of AI-powered biology - the future of the bioeconomy!

Connect:
Nicholas on Linkedin: https://www.linkedin.com/in/nlarusstone/
Benchling: https://www.benchling.com/

]]> biotech, synthetic, AI, futurism, biology, pharmaceuticals, research No Finding the Next TechBio Unicorn with Krish Ramadurai, AIX Ventures 3 3 Finding the Next TechBio Unicorn with Krish Ramadurai, AIX Ventures full a9427e73-087a-4957-abd9-3e8ae1c545ea https://talkBIOtome.transistor.fm/3 Ever wonder what separates a billion-dollar TechBio unicorn from a well-funded experiment? Krish Ramadurai of AIX Ventures does—and he's backed some of the coolest ones. We dive into why understanding the actual science matters, why mice are terrible at predicting human outcomes (sorry, lab mice), and how the next generation of drug discovery is being built by teams brave enough to let AI nerds and wet lab scientists actually talk to each other. Plus, he'll tell you why he thinks you should care about making drugs people can actually afford.

]]> Ever wonder what separates a billion-dollar TechBio unicorn from a well-funded experiment? Krish Ramadurai of AIX Ventures does—and he's backed some of the coolest ones. We dive into why understanding the actual science matters, why mice are terrible at predicting human outcomes (sorry, lab mice), and how the next generation of drug discovery is being built by teams brave enough to let AI nerds and wet lab scientists actually talk to each other. Plus, he'll tell you why he thinks you should care about making drugs people can actually afford.

]]> Tue, 23 Jun 2026 14:20:52 -0400 Chorus Studios Chorus Studios 1110 Ever wonder what separates a billion-dollar TechBio unicorn from a well-funded experiment? Krish Ramadurai of AIX Ventures does—and he's backed some of the coolest ones. We dive into why understanding the actual science matters, why mice are terrible at predicting human outcomes (sorry, lab mice), and how the next generation of drug discovery is being built by teams brave enough to let AI nerds and wet lab scientists actually talk to each other. Plus, he'll tell you why he thinks you should care about making drugs people can actually afford.

]]> biotech, synthetic, AI, futurism, biology, pharmaceuticals, research No From Pollution to Designer Jacket? It's in the Microbe. 2 2 From Pollution to Designer Jacket? It's in the Microbe. full 20280fa7-ef3c-49d2-9848-af5932f0b25f https://talkBIOtome.transistor.fm/2 In this episode, Flo sits down with Dr. Michael Köpke, Chief Innovation Officer at LanzaTech, to explore how specialized microbes are literally eating industrial emissions and transforming them into valuable products (Michael's cool Jacket!). From sustainable aviation fuels to the jacket Michael is wearing—which started its life as emissions from a steel plant—LanzaTech's carbon-fixing microbes are closing the loop on our circular economy. Michael shares his journey from academic microbiology research to commercializing this breakthrough technology, and reveals how LanzaTech now operates six commercial plants globally, capturing half a million tons of CO2 annually while producing 300,000 tons of products. Discover how nature's zero-waste systems are inspiring the next generation of biomanufacturing and how waste gases are becoming the feedstock for a sustainable future.

Connect with Dr. Michael Kopke on X and Linkedin.

More about Michael and LanzaTech: Dr. Michael Köpke is the Chief Innovation Officer at LanzaTech ($LNZA), a global leader in carbon capture and sustainable fuels, chemicals, and materials production. Since joining the company in 2009, he has built up the company's biology platform and directs innovation strategy and technology partnerships.


Michael earned his Ph.D. in biotechnology from Ulm University and brings over two decades of international experience in synthetic biology and biomanufacturing. Widely recognized as a pioneer in carbon-fixing microbial technologies, Dr. Köpke holds more than 500 patents and received major honors such as the Presidential Green Chemistry Challenge Award, the ACS National Award for Team Innovation, and inclusion in The Bioeconomy 500.


Beyond his role at LanzaTech, Dr. Köpke is an adjunct professor at Northwestern University and serves on the boards of the Engineering Biology Research Consortium (EBRC) and the International Metabolic Engineering Society (IMES). Michael has led over 50 peer reviewed studies and development of community research roadmaps bringing together stakeholders from academia, industry, government and non-profits. Michael also chaired several international conferences and contributes in several editorial, education and advisory functions.

]]> In this episode, Flo sits down with Dr. Michael Köpke, Chief Innovation Officer at LanzaTech, to explore how specialized microbes are literally eating industrial emissions and transforming them into valuable products (Michael's cool Jacket!). From sustainable aviation fuels to the jacket Michael is wearing—which started its life as emissions from a steel plant—LanzaTech's carbon-fixing microbes are closing the loop on our circular economy. Michael shares his journey from academic microbiology research to commercializing this breakthrough technology, and reveals how LanzaTech now operates six commercial plants globally, capturing half a million tons of CO2 annually while producing 300,000 tons of products. Discover how nature's zero-waste systems are inspiring the next generation of biomanufacturing and how waste gases are becoming the feedstock for a sustainable future.

Connect with Dr. Michael Kopke on X and Linkedin.

More about Michael and LanzaTech: Dr. Michael Köpke is the Chief Innovation Officer at LanzaTech ($LNZA), a global leader in carbon capture and sustainable fuels, chemicals, and materials production. Since joining the company in 2009, he has built up the company's biology platform and directs innovation strategy and technology partnerships.


Michael earned his Ph.D. in biotechnology from Ulm University and brings over two decades of international experience in synthetic biology and biomanufacturing. Widely recognized as a pioneer in carbon-fixing microbial technologies, Dr. Köpke holds more than 500 patents and received major honors such as the Presidential Green Chemistry Challenge Award, the ACS National Award for Team Innovation, and inclusion in The Bioeconomy 500.


Beyond his role at LanzaTech, Dr. Köpke is an adjunct professor at Northwestern University and serves on the boards of the Engineering Biology Research Consortium (EBRC) and the International Metabolic Engineering Society (IMES). Michael has led over 50 peer reviewed studies and development of community research roadmaps bringing together stakeholders from academia, industry, government and non-profits. Michael also chaired several international conferences and contributes in several editorial, education and advisory functions.

]]> Tue, 16 Jun 2026 15:29:33 -0400 Chorus Studios Chorus Studios 513 In this episode, Flo sits down with Dr. Michael Köpke, Chief Innovation Officer at LanzaTech, to explore how specialized microbes are literally eating industrial emissions and transforming them into valuable products (Michael's cool Jacket!). From sustainable aviation fuels to the jacket Michael is wearing—which started its life as emissions from a steel plant—LanzaTech's carbon-fixing microbes are closing the loop on our circular economy. Michael shares his journey from academic microbiology research to commercializing this breakthrough technology, and reveals how LanzaTech now operates six commercial plants globally, capturing half a million tons of CO2 annually while producing 300,000 tons of products. Discover how nature's zero-waste systems are inspiring the next generation of biomanufacturing and how waste gases are becoming the feedstock for a sustainable future.

Connect with Dr. Michael Kopke on X and Linkedin.

More about Michael and LanzaTech: Dr. Michael Köpke is the Chief Innovation Officer at LanzaTech ($LNZA), a global leader in carbon capture and sustainable fuels, chemicals, and materials production. Since joining the company in 2009, he has built up the company's biology platform and directs innovation strategy and technology partnerships.


Michael earned his Ph.D. in biotechnology from Ulm University and brings over two decades of international experience in synthetic biology and biomanufacturing. Widely recognized as a pioneer in carbon-fixing microbial technologies, Dr. Köpke holds more than 500 patents and received major honors such as the Presidential Green Chemistry Challenge Award, the ACS National Award for Team Innovation, and inclusion in The Bioeconomy 500.


Beyond his role at LanzaTech, Dr. Köpke is an adjunct professor at Northwestern University and serves on the boards of the Engineering Biology Research Consortium (EBRC) and the International Metabolic Engineering Society (IMES). Michael has led over 50 peer reviewed studies and development of community research roadmaps bringing together stakeholders from academia, industry, government and non-profits. Michael also chaired several international conferences and contributes in several editorial, education and advisory functions.

]]> lanzatech, microbes, emissions, biotech, carboncapture, pollution, innovation No Who Knew Spores were so Metal?! Chris Kantrowitz, Quorum Earth 1 1 Who Knew Spores were so Metal?! Chris Kantrowitz, Quorum Earth full 58360b76-5ea4-41de-9816-165e6f1a970f https://talkBIOtome.transistor.fm/1 Meet Chris Kantrowitz, founder of Quorum Earth, who's literally making fungal spores that eat bugs—and he's weirdly charming about it. In this first episode of Talk Bio to Me, Chris breaks down how specialized fungal spores are taking on invasive species without any CRISPR or GMO shenanigans, just pure fungal magic. 

]]> Meet Chris Kantrowitz, founder of Quorum Earth, who's literally making fungal spores that eat bugs—and he's weirdly charming about it. In this first episode of Talk Bio to Me, Chris breaks down how specialized fungal spores are taking on invasive species without any CRISPR or GMO shenanigans, just pure fungal magic. 

]]> Fri, 12 Jun 2026 10:30:32 -0400 Chorus Studios Chorus Studios 676 Meet Chris Kantrowitz, founder of Quorum Earth, who's literally making fungal spores that eat bugs—and he's weirdly charming about it. In this first episode of Talk Bio to Me, Chris breaks down how specialized fungal spores are taking on invasive species without any CRISPR or GMO shenanigans, just pure fungal magic. 

]]> biotech, synthetic, AI, futurism, biology, pharmaceuticals, research No Talk BIO to Me... 1 1 Talk BIO to Me... trailer 1c87d931-ab77-400f-b6e2-e43746adc94c https://talkBIOtome.transistor.fm/trailer1 Welcome to Talk BIO to Me! The show where we sit down with the people building the future of biology. This year, we headed to SynBioBeta, the world's largest conference for synthetic biology. This mini-series (or mini-pod) features interviews with some of the most fascinating founders, scientists, researchers, investors, and AI innovators shaping the future of biotech. Subscribe to get the first two episodes in your feed this week!

]]> Welcome to Talk BIO to Me! The show where we sit down with the people building the future of biology. This year, we headed to SynBioBeta, the world's largest conference for synthetic biology. This mini-series (or mini-pod) features interviews with some of the most fascinating founders, scientists, researchers, investors, and AI innovators shaping the future of biotech. Subscribe to get the first two episodes in your feed this week!

]]> Mon, 08 Jun 2026 12:39:44 -0400 Chorus Studios Chorus Studios 86 Welcome to Talk BIO to Me! The show where we sit down with the people building the future of biology. This year, we headed to SynBioBeta, the world's largest conference for synthetic biology. This mini-series (or mini-pod) features interviews with some of the most fascinating founders, scientists, researchers, investors, and AI innovators shaping the future of biotech. Subscribe to get the first two episodes in your feed this week!

]]> biotech, synthetic, AI, futurism, biology, pharmaceuticals, research No